Clin2
NCT07639684Possibly a fitNot yet recruiting

Endoscopic sleeve gastroplasty for adults with type 2 diabetes and obesity

Type 2 Diabetes Mellitus (T2D)Obesity (BMI>30)

Part of Hormones & metabolism clinical trials.

This study tests a procedure called endoscopic sleeve gastroplasty, which uses a device to reduce the size of your stomach without surgery. It aims to see if this helps improve blood sugar control and weight in adults with type 2 diabetes and obesity.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
50 people
Ages
22 years and older
Study type
Interventional

Who can take part

  • You are at least 22 years old.
  • Your body mass index (BMI) is between 30 and 50.
  • You have type 2 diabetes with an HbA1c between 7.5% and 10.5%.
  • You are currently taking a GLP-1 medication (like Ozempic or Mounjaro) at a stable dose for at least 6 months.
  • Your weight has been stable (no more than 5% change) in the last 3 months.
  • You are willing to follow a lifestyle program and attend study visits for a year.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07798219Not yet recruiting
Stomach size reduction for weight loss in people with heart failure

This study tests a weight-loss procedure called endoscopic sleeve gastroplasty, which uses an endoscope (a flexible tube with a camera) to reduce the size of your stomach, helping you eat less and lose weight. It is designed for people who have both obesity and a type of heart failure called HFpEF (heart failure with preserved ejection fraction), and aims to improve heart symptoms and quality of life.

Los Angeles, California
NCT06657339Not yet recruiting
National registry for endoscopic sleeve gastrectomy for obesity

This study tracks people with obesity who get an endoscopic sleeve gastrectomy, a procedure that reduces stomach size without surgery. The goal is to see how safe and effective it is in everyday practice.

NCT07449520Not yet recruiting
Endoscopic sleeve gastroplasty for weight loss

This trial tests a procedure called Endoscopic Sleeve Gastroplasty (ESG) as a non-surgical option for weight loss. It aims to help people who have not been able to lose weight with diet and exercise, and who either cannot or prefer not to have bariatric surgery.

Aix-en-Provence
NCT06914765Enrolling by invitation
Endoscopic sleeve gastroplasty for teens with obesity

This study tests a new, non-surgical procedure called Endoscopic Sleeve Gastroplasty (ESG) to help teenagers with severe obesity lose weight. The goal is to see if it can improve their health and help them reach a healthier weight.

Philadelphia, Pennsylvania
NCT07576777Not yet recruiting
Hormone and gut bacteria changes after endoscopic sleeve gastroplasty

This study looks at how a procedure called endoscopic sleeve gastroplasty (a way to reduce stomach size without surgery) affects hormones and gut bacteria. It may help people with obesity lose weight and improve related health issues.

Paris, Paris
NCT06339320Recruiting
Stomach stitching for weight loss

This trial tests a non-surgical procedure called Endoscopic Sleeve Gastroplasty (ESG) to help people with obesity lose weight. A doctor uses a thin tube with a camera to stitch your stomach smaller, so you feel full sooner.

Houston, Texas

Hear when a new Obesity (BMI>30) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.